PL3856151T3 - Liofilizat treosulfanu - Google Patents

Liofilizat treosulfanu

Info

Publication number
PL3856151T3
PL3856151T3 PL19778493.7T PL19778493T PL3856151T3 PL 3856151 T3 PL3856151 T3 PL 3856151T3 PL 19778493 T PL19778493 T PL 19778493T PL 3856151 T3 PL3856151 T3 PL 3856151T3
Authority
PL
Poland
Prior art keywords
treosulfan
lyophilisate
Prior art date
Application number
PL19778493.7T
Other languages
English (en)
Inventor
Sebastian Bialleck
Original Assignee
Medac Gesellschaft für klinische Spezialpräparate mbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medac Gesellschaft für klinische Spezialpräparate mbH filed Critical Medac Gesellschaft für klinische Spezialpräparate mbH
Publication of PL3856151T3 publication Critical patent/PL3856151T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/07Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
    • C07C309/08Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL19778493.7T 2018-09-26 2019-09-25 Liofilizat treosulfanu PL3856151T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18196967 2018-09-26
PCT/EP2019/075832 WO2020064819A1 (en) 2018-09-26 2019-09-25 Lyophilisate of treosulfan

Publications (1)

Publication Number Publication Date
PL3856151T3 true PL3856151T3 (pl) 2024-02-19

Family

ID=63685769

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19778493.7T PL3856151T3 (pl) 2018-09-26 2019-09-25 Liofilizat treosulfanu

Country Status (15)

Country Link
US (1) US12178914B2 (pl)
EP (2) EP4257122B1 (pl)
JP (3) JP7776985B2 (pl)
CN (1) CN112752569B (pl)
CA (1) CA3113705A1 (pl)
DK (1) DK3856151T3 (pl)
EA (1) EA202190616A1 (pl)
ES (1) ES2964602T3 (pl)
FI (1) FI3856151T3 (pl)
HR (1) HRP20231343T1 (pl)
HU (1) HUE064508T2 (pl)
LT (1) LT3856151T (pl)
PL (1) PL3856151T3 (pl)
PT (1) PT3856151T (pl)
WO (1) WO2020064819A1 (pl)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB891466A (en) 1958-04-24 1962-03-14 Nat Res Dev New methane sulphonic acid esters of polyols
GB896052A (en) 1960-02-22 1962-05-09 Knud Abildgaard The stereo-isomers and the racemate of butane-1,2,3,4-tetrol-1,4-di-(methanesulphonate)
DE1188583B (de) 1960-02-22 1965-03-11 Leo Pharm Prod Ltd Verfahren zur Herstellung der Steroisomeren und des Racemats von Butan-1, 2, 3, 4-tetrol-1, 4-di-(methansulfonat)
DE1193938B (de) 1961-10-02 1965-06-03 Leo Pharm Prod Ltd Verfahren zur Herstellung des Racemats und der Stereoisomeren einschliesslich des Mesoisomeren von Butan-1, 2, 3, 4-tetrol-1, 4-di-(methansulfonat)
DE19936281C2 (de) 1999-08-02 2002-04-04 Bayer Ag Verfahren zur Gefriertrocknung
DE19953517C1 (de) 1999-11-05 2001-08-09 Medac Klinische Spezialpraep Verwendung von Treosulfan zur Konditionierung von Patienten vor Knochemarktransplantation oder Blutstammzelltransplantation
US8793895B2 (en) 2006-02-10 2014-08-05 Praxair Technology, Inc. Lyophilization system and method
AR077384A1 (es) 2010-07-05 2011-08-24 Eriochem Sa Una formulacion farmaceutica inyectable de melfalano.
EP2958554B1 (en) 2013-02-19 2018-06-06 Synthon BV Stable compositions of bendamustine
WO2015107534A1 (en) 2013-11-04 2015-07-23 Emcure Pharmaceuticals Limited Lyophilized formulation of treosulfan

Also Published As

Publication number Publication date
JP2022509904A (ja) 2022-01-25
JP7776985B2 (ja) 2025-11-27
EP4257122A3 (en) 2024-01-10
JP2025137705A (ja) 2025-09-19
HRP20231343T1 (hr) 2024-02-16
FI3856151T3 (fi) 2023-11-15
US12178914B2 (en) 2024-12-31
PT3856151T (pt) 2023-10-27
CA3113705A1 (en) 2020-04-02
CN112752569A (zh) 2021-05-04
CN112752569B (zh) 2025-07-04
HUE064508T2 (hu) 2024-03-28
DK3856151T3 (da) 2023-11-27
LT3856151T (lt) 2023-11-27
EP4257122A2 (en) 2023-10-11
EP3856151B1 (en) 2023-08-23
ES2964602T3 (es) 2024-04-08
EP3856151A1 (en) 2021-08-04
EP4257122B1 (en) 2026-03-11
US20220031620A1 (en) 2022-02-03
EA202190616A1 (ru) 2021-06-25
WO2020064819A1 (en) 2020-04-02
JP2023153362A (ja) 2023-10-17

Similar Documents

Publication Publication Date Title
ZA202103713B (en) Mobility procedure
GB201804514D0 (en) Treatment of pyroptosis
IL283948A (en) Methods for treating depression
SG11202103253YA (en) Therapeutic compounds
ZA201906238B (en) New therapeutical use of h3-ligands
GB201815483D0 (en) Therapeutic bacteriophages
GB201804515D0 (en) Treatment of necroptosis
EP3355894A4 (en) COMPOSITION FOR MAINTAINING LACTOBACILLUS DOMINANCE
GB201816554D0 (en) Novel compounds and therapeutic uses thereof
GB201816553D0 (en) Novel compounds and therapeutic uses thereof
GB201808150D0 (en) Therapeutic compounds
IL267227A (en) Methods of administering hepcidin
SI3781172T1 (sl) Zdravljenje pljučnice
GB201804098D0 (en) Novel compounds and therapeutic uses thereof
GB201808575D0 (en) Methods for the treatment of psoriatic arthrits
PT3856151T (pt) Liofilizado de treossulfano
SG11202105136WA (en) Application of chidamide
IL269681A (en) New methods for treating multiple sclerosis
CA187131S (en) Casket
GB201712884D0 (en) Novel therapeutic compounds
PT3901141T (pt) Nova forma de isoquinolinossulfonamida
HK40048002A (en) Crystalline form of treosulfan
GB2573210B (en) Casket
GB201810835D0 (en) Methods of use
ZA201901803B (en) Casket